Frontier Capital Management Co. LLC Has $3.29 Million Stake in Stratasys Ltd. (NASDAQ:SSYS)

Frontier Capital Management Co. LLC raised its position in Stratasys Ltd. (NASDAQ:SSYS) by 6.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 370,137 shares of the technology company’s stock after acquiring an additional 21,977 shares during the quarter. Frontier Capital Management Co. LLC owned approximately 0.52% of Stratasys worth $3,291,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. D. E. Shaw & Co. Inc. lifted its stake in Stratasys by 278.6% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 237,415 shares of the technology company’s stock valued at $2,111,000 after purchasing an additional 174,704 shares during the last quarter. Cubist Systematic Strategies LLC lifted its position in shares of Stratasys by 16.4% in the fourth quarter. Cubist Systematic Strategies LLC now owns 75,117 shares of the technology company’s stock valued at $668,000 after buying an additional 10,570 shares during the last quarter. Balyasny Asset Management L.P. acquired a new position in shares of Stratasys during the 4th quarter worth approximately $247,000. Bayesian Capital Management LP bought a new stake in Stratasys in the 4th quarter valued at $217,000. Finally, BNP Paribas Financial Markets lifted its holdings in Stratasys by 46.6% during the 4th quarter. BNP Paribas Financial Markets now owns 190,135 shares of the technology company’s stock valued at $1,690,000 after purchasing an additional 60,407 shares during the last quarter. Institutional investors own 75.77% of the company’s stock.

Stratasys Price Performance

Stratasys stock opened at $11.03 on Friday. The firm has a market cap of $791.03 million, a PE ratio of -8.36 and a beta of 1.50. The stock’s fifty day moving average price is $9.66 and its two-hundred day moving average price is $9.64. Stratasys Ltd. has a one year low of $6.05 and a one year high of $12.88.

Stratasys (NASDAQ:SSYS) last issued its quarterly earnings results on Thursday, May 8th. The technology company reported $0.04 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. The company had revenue of $136.05 million for the quarter, compared to analysts’ expectations of $134.11 million. Stratasys had a negative return on equity of 3.75% and a negative net margin of 16.13%. Stratasys’s revenue was down 5.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.02) earnings per share. Sell-side analysts expect that Stratasys Ltd. will post -0.4 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on SSYS shares. Cantor Fitzgerald increased their price objective on shares of Stratasys from $12.00 to $15.00 and gave the company an “overweight” rating in a research report on Tuesday, March 4th. StockNews.com downgraded Stratasys from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, Needham & Company LLC boosted their price target on Stratasys from $12.00 to $13.00 and gave the company a “buy” rating in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $12.20.

Stratasys Company Profile

Stratasys Ltd. provides connected polymer-based 3D printing solutions. It offers range of 3D printing systems, which includes polyjet printer, Fused Deposition Modeling (FDM) printers, stereolithography printing systems, origin P3 printers, and selective absorption fusion printer for additive manufacturing, and tooling and rapid prototyping for various vertical markets, such as automotive, aerospace, consumer products and healthcare.